extract EGb761 has been confirmed to have protective effects on neurons against oxidative stress. Notably, several clinical trials have shown that patients with stable vitiligo achieved repigmentation after taking EGb761. However, the exact mechanism underlying the protective effects of EGb761 on melanocytes against oxidative stress has not been fully elucidated. In the present study, we found that EGb761 effectively protected melanocytes against oxidative stress-induced apoptosis and alleviated the excessive accumulation of reactive oxygen species (ROS) and lipid peroxidation by enhancing the activity of antioxidative enzymes. Furthermore, the antioxidative effect of EGb761 was achieved by activating Nrf2 and its downstream antioxidative genes.
In addition, interfering Nrf2 with siRNA abolished the protective effects of EGb761 on melanocytes against oxidative damage. In conclusion, our study proves that EGb761 could protect melanocytes from H 2 O 2 -induced oxidative stress by activating Nrf2. Therefore, EGb761 is supposed to be a potential therapeutic agent for vitiligo.
K E Y W O R D S
EGb761, Melanocyte, Nrf2, Oxidative stress, Vitiligo EGb761 could prevent hippocampus neurons from oxidative damage by enhancing antioxidative ability of neurons, improving the microenvironment for nerve regeneration and promoting the proliferation of nerve cells. 4, 6, 7 It is known that melanocytes originate from neural crest, so it has raised concerns about how EGb761 affects the growth of melanocyte cell lines in recent years. One study reported that EGb761 could protect melanocytes against oxidative stress by activating antioxidase and inhibiting endoplasmic reticulum stress. 8 However, some other studies have controversial findings that Ginkgo biloba or its principal components could induce the apoptosis of melanoma cells. 9, 10 Notably, several clinical trials have illustrated that the application of Ginkgo biloba extract can prevent the onset and the progression of vitiligo, indicating its therapeutic potential in treating vitiligo. 11 However, the exact mechanism underlying the effect of EGb761 on vitiligo remains unclear.
The transcription factor nuclear erythroid 2-related factor 
| MATERIAL S AND ME THODS

| Experimental reagents and antibodies
The following reagents were obtained from the indicated commer- were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The antibodies against Nrf2, HO-1, NQO1 and SOD2
were purchased from Cell Signaling Technology (Boston, MA, US). 
| Cell culture and treatment
| Measurement of antioxidant enzymes
| Measurement of MDA levels
Malondialdehyde in cells was measured using commercial kits according to the manufacturer's recommendations. The absorbance of the supernatant was determined at 532 and 600 nm. Malondialdehyde levels were expressed as nmol/mg protein.
| Measurement of intracellular reactive oxygen species
Reactive oxygen species was monitored using dihydrodichlorofluo- 
| Protein extraction and Western blot analysis
After the completion of respective treatments, PIG1 cells were harvested and cellular protein lysate was prepared using lysis buffer [20 mmol/L Tris-HCl, 120 mmol/L NaCl, 1.0% Triton X 100, pH 7.5, 10% glycerol, 2 mmol/L EDTA and protease inhibitor cocktail (Roche GmbH, Germany)] at 4°C for 30 min. After centrifugation at 10 000 g for 20 minutes, the supernatant was separated and stored at −80°C until use. Protein concentrations were determined using 1× Bradford protein assay kit according to the manufacturer's instructions (BioRad, Hercules, CA) with bovine serum albumin (BSA) as a standard.
For Western blot, equal amounts of protein lysates were separated in 10% sodium dodecyl sulphate-polyacrylamide (SDS-PAGE) gel electrophoresis. The gels were blotted onto a nitrocellulose membrane and incubated with the indicated antibodies. Blots were developed by enhanced chemiluminescence (ECL) according to the manufacturer's instructions. Actin was used as a loading control.
| Quantitative polymerase chain reaction
Total RNA was extracted using the TRIzol Reagent (Invitrogen, Carlsbad, CA). RNA concentrations and purities were determined by measuring the absorbance at 260 nm. First-strand cDNA was generated using SuperScript III first-strand synthesis system as 
| Statistical analysis
The statistical analyses were performed using spss 16.0 (SPSS Inc, Chicago, IL). All the values were presented as mean ± standard deviation (SD). Statistical analysis was performed by two-tailed Student's t test or ANOVAs, followed by Bonferroni/Dunn post hoc comparisons. P < 0.05 was regarded statistically significant.
| RE SULTS
| EGb761 improves cell viability and inhibits the production of ROS and lipid peroxidation in melanocytes under oxidative stress
To examine whether EGb761 could protect melanocytes under oxidative stress, we built the oxidative stress model of melanocytes based on our previous studies, which was made by treating PIG1 cells with Data are presented as the mean ± SD, *P < 0.05, **P < 0.01, ***P < 0.001 (Figure 2A ,B).
| EGb761 restores the activity of SOD and GSHPx in melanocytes under oxidative stress
| EGb761 activates Nrf2-ARE signaling pathway in melanocytes under oxidative stress
To further identify whether the protective effect of EGb761 on melanocytes under oxidative stress is dependent on Nrf2-ARE pathway, the mRNA and protein levels of Nrf2 and its downstream genes were detected in PIG1 cells treated with H 2 O 2 by qPCR and Western blot respectively. As is illustrated in Figure 3B 
| Nrf2 knockdown diminishes the protective effect of EGb761 on melanocytes under oxidative stress
To further demonstrate the involvement of Nrf2 on the protective effect of EGb761 on melanocytes under oxidative stress, we established PIG1 cell lines with Nrf2 knockdown by using siRNA transfection. After the transfection with si-Nrf2, the protein levels of
Nrf2 and its downstream genes including NQO-1, HO-1 and SOD2
were reduced by 89%, 53%, 67% and 82% respectively ( Figure S1 ).
We further found that the pretreatment with EGb761 effectively Three repeated experiments were made, and paired t test was used to make statistics. Data are presented as the mean ± SD, *P < 0.05, **P < 0.01, ***P < 0.001 
| D ISCUSS I ON
In the present study, we primarily found that EGb761 could prevent melanocyte death under oxidative stress, inhibit the accumulation of ROS and enhance the activity of antioxidants. Moreover, the protective effect of EGb761 on melanocytes under oxidative stress was dependent on the activation of Nrf2 and its downstream antioxidative genes including NQO-1, SOD2 and HO-1. Therefore, EGb761 could be an effective agent in protecting melanocytes against oxidative damage.
Ginkgo biloba extract has been applicated as an antioxidant to treat several oxidative stress-related diseases like Alzheimer's disease or acute ischaemic stroke. 4, 6, 22 Oxidative stress plays a pivotal role in the pathogenesis of vitiligo, 23 thus it has gained concerns about whether Ginkgo biloba extract has therapeutic effect on vitiligo. A previous study has suggested that EGb761 could protect melanocytes from Three repeated experiments were made, and paired t test was used to make statistics. Data are presented as the mean ± SD, *P < 0.05, **P < 0.01
In the present study, we initially found that EGb761 showed no toxic effect on PIG1 cells (data not shown), which was consistent with previous studies. 10 The patients with vitiligo have inferior capacity against oxidative stress due to the lower activity of SOD and GSHPx. 20 26 A clinical study reported that vitiligo patients achieved repigmentation by using 40 mg of Ginkgo biloba extract TID with slight adverse effects like mild nausea. 24 In the present study, 100 μg/ml of EGb761, which was lower than the concentration of EGb761 for treating other diseases, could effectively protect melanocytes against H 2 O 2 -induced oxidative damage.
Therefore, the application of this concentration would be safe to vitiligo patients.
In conclusion, EGb761 can protect melanocytes against oxidative stress damage through the activation of Nrf2-ARE signaling pathway. Our study provides a new strategy in treating vitiligo with traditional Chinese medicine. As EGb761 is widely used in the treatment of oxidative stress-related diseases with remarkable safety and tolerance, its application in the treatment of vitiligo is prospective. . The pretreatment with EGb761 increased the levels of Nrf2, SOD2, HO-1 and NQO1 in si-NC group, which was not observed in si-Nrf2 group. The cell viability (B) and ROS level (C) of cells were determined respectively. Compared with single H 2 O 2 -treated cells, the pretreatment with EGb761 significantly increased the number of viable cells in the si-NC group, whereas the percentage of viable cells was further decreased and it failed to reverse in si-Nrf2 group. The ability of EGb761 to inhibit ROS levels was also diminished in si-Nrf2 group. Three repeated experiments were made, and paired t test was used to make statistics. Data are presented as the mean ± SD, *P < 0.05, **P < 0.01
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